ArticleFamilial cancer2022
Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators.
Muhammad Salman Faisal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it